-
Outcomes of CML Treatment Shift with 2G-TKIs as 1L Therapy
12 Apr 2024 15:09 GMT
… “Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction … on their TKI treatment timeline: up to December 2010 (imatinib era group … than in the imatinib era.
Investigators concluded that expanding treatment options likely …
-
Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”
09 Apr 2024 12:30 GMT
… Phase 3, development-stage pharmaceutical company focused on identifying … Burkhoff obtained Doctor of Philosophy and Medical degrees from … , device and pharmacologic treatments for heart failure, … unique oral formulation of imatinib. For more information …
-
Orphan designation: imatinib Treatment of pulmonary arterial hypertension, 21/06/2021 Positive
08 Apr 2024 16:03 GMT
… designated as an orphan medicine for the treatment of pulmonary arterial hypertension … , doctors may be able to enrol patients in clinical trials investigating the medicine. For … clinical trials in the EU, see:
How the medicine is expected to work
Imatinib …
-
25 drugs at Mark Cuban's online pharmacy with biggest cost reductions
06 Apr 2024 00:30 GMT
… Drugs now sells hundreds of generics and about 20 branded medications … pharmacy benefit managers.
Each drug is priced at its … medications with the biggest price cuts sold at Cost Plus Drugs …
Savings: $2,489.20
Imatinib (generic for Gleevec)
Retail …
-
Opinion: Personalized medicine: We’re not there yet
05 Apr 2024 12:53 GMT
… accessing the tests and treatments underpinning personalized medicine.
20 years of progress … (trastuzumab), Iressa (gefitinib), and Gleevec (imatinib) had only recently become available … all clinical trials in cancer care are now for drugs that are …
-
Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
03 Apr 2024 12:05 GMT
… Company”), a clinical-stage pharmaceutical company developing protein kinase … imatinib treatment in PAH. We look forward to the FDA … #39;s RAMP™ medicinal chemistry program has identified … successfully conduct clinical trials that are statistically significant …
-
Lawmakers want to add more Chinese biotechs to defense list
02 Apr 2024 15:23 GMT
… in a Phase 2 trial. The drug blocks two proteins, … formulation of the cancer medicine imatinib, which has been repurposed … FDA has approved Rejoyn, Otsuka Pharmaceutical’s smartphone-based digital treatment … to be used alongside antidepressants. The six-week …
-
FDA Approvals in the Blood Cancer Space from Winter 2024
01 Apr 2024 21:19 GMT
… , the Food and Drug Administration (FDA) approved multiple new … that, according to one doctor, may be more convenient … 3 PhALLCON trial, which compared Iclusig to Gleevec (imatinib) in … of cancer detected after treatment)-negative complete response rate …
-
How does AI drug discovery really work? A new paper reveals the process
01 Apr 2024 10:44 GMT
… drugs in or entering clinical trials.
But as more of these treatments … Nature Biotechnology from biotech company Insilico Medicine helps … , medicinal chemistry design and clinical trial components … success rate of pharmaceutical development. It still …
-
FDA Approved Drug Products Approval List March 2024
30 Mar 2024 10:39 GMT
… #021588 SUPPL-63 IMATINIB MESYLATE NOVARTIS Manufacturing (CMC … ORIG-1 RIFAXIMIN NORWICH PHARMACEUTICALS INC Tentative Approval 03 … 761044 SUPPL-13 USTEKINUMAB JANSSEN BIOTECH Approval 03… SUPPL-15 PRALSETINIB BLUEPRINT MEDICINES Labeling Approval 03…